The Latest Breaking News from Covid-19

India reports 12,608 new Covid cases and 72 deaths in last 24 hours

NEW DELHI: India on Thursday reported 12,608 Coronavirus cases and 72 deaths. The total deaths reported in the country during the pandemic has now reached, 5,27,206.

The Times of India · Aug 18, 2022

Long Covid is impacting men’s sex lives, warns GP

Long Covid has a much more extensive list of symptoms than originally thought, new research has revealed

Manchester Evening News · Aug 18, 2022

No new COVID-19 deaths as cases remain low

There were 384 new cases of COVID-19 reported in the territory.

The Canberra Times · Aug 18, 2022

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga · Aug 17, 2022

Thousands to receive AS and A-level results across Northern Ireland

This year saw student sit exams after several years of disruption during the coronavirus pandemic.

The Independent UK · Aug 17, 2022

Rank Group sees the return of high-rolling London visitors after slow start to summer

Middle Eastern gamblers are coming back into the capital’s casinos

Evening Standard · Aug 17, 2022

Premier League financially ‘further ahead than ever’ after Covid-hit season, Deloitte report shows

Deloitte’s Annual Review of Football Finance underlined the financial gulf between the Premier League and the rest of Europe

The Independent UK · Aug 17, 2022

‘No room for complacency in upping representation of black students at Oxbridge’

Black Year 12 pupils have been disproportionately affected by the fallout of the coronavirus pandemic, the Target Oxbridge programme said.

The Independent UK · Aug 17, 2022

Mary Portas hits out at government ‘sh*t show’ as high street businesses fear inflation

Former advisor to Tory prime minister calls the lack of action due to Truss v Sunak leadership contest ‘ridiculous’

Evening Standard · Aug 17, 2022

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Benzinga · Aug 17, 2022